Harte Hanks, Inc (HHS) Key Metrics
HHS valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $32.0M
- Enterprise value
- $53.4M
- P/E (TTM)
- — 10-yr median 2.4
- Forward P/E
- 14.3
- PEG ratio
- 1.19
- Price / sales
- 0.2 10-yr median 0.2
- Price / book
- 2.2 10-yr median 2.5
- EV / EBITDA
- 4.5 10-yr median 4.4
- Dividend yield
- —
- Beta
- 0.17
HHS key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsHHS valuation Price multiples at each fiscal year-end price.
HHS returns How much profit the business earns on the capital it uses.
HHS per-share figures Results divided by the shares outstanding at year-end.
HHS financial health Debt, liquidity and how easily interest is covered.
HHS efficiency & capital use Working capital cycle and where the cash goes.
HHS valuation history
HHS returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
HHS debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
HHS cash returned to shareholders
HHS price vs earnings per share
HHS key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $22.3M | $37.6M | $49.6M | $86.5M | $54.8M | $17.8M | $22.5M | $15.2M | $58.8M | $92.8M |
| Enterprise value | $39.1M | $52.2M | $59.8M | $98.5M | $73.6M | $43.4M | $27.8M | $15.3M | $61.5M | $87.3M |
| P/E ratio | — | — | — | 2.4 | 3.7 | — | — | 0.9 | — | — |
| Price / sales | 0.1 | 0.2 | 0.3 | 0.4 | 0.3 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Price / book | 1.1 | 1.7 | 2.5 | 4.6 | — | — | — | — | — | 35.0 |
| Price / free cash flow | — | — | 6.5 | 3.8 | — | — | 2.4 | — | — | 11.8 |
| Price / operating cash flow | — | — | 4.7 | 3.0 | — | — | 1.9 | — | — | 6.4 |
| EV / sales | 0.2 | 0.3 | 0.3 | 0.5 | 0.4 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 |
| EV / EBITDA | 11.3 | 4.3 | 4.5 | 4.4 | 3.7 | — | — | — | — | — |
| EV / free cash flow | — | — | 7.8 | 4.3 | — | — | 3.0 | — | — | 11.0 |
| Earnings yield | −3.6% | −80.7% | −3.2% | 42.5% | 27.3% | −9.5% | −116.7% | 115.7% | −71.2% | −141.0% |
| Free cash flow yield | −20.2% | −17.9% | 15.4% | 26.6% | −8.8% | −59.2% | 40.9% | −88.2% | −62.0% | 8.5% |
| Dividend yield | — | — | — | — | — | — | 20.0% | 217.0% | 51.2% | 5.7% |
| Shareholder yield (dividends + buybacks) | 0.3% | 0.8% | 6.1% | 0.5% | 0.5% | 0.1% | 20.0% | 217.7% | 51.4% | 5.9% |
| Share price at fiscal year-end | $3.01 | $5.15 | $6.79 | $11.69 | $7.60 | $2.75 | $3.58 | $2.42 | $9.50 | $15.10 |
| Per share | ||||||||||
| Revenue per share | $21.58 | $25.40 | $26.20 | $27.87 | $26.99 | $27.35 | $34.62 | $45.40 | $62.00 | $65.77 |
| Earnings per share | −$0.11 | −$4.15 | −$0.21 | $4.97 | $2.08 | −$0.26 | −$4.18 | $2.80 | −$6.76 | −$21.30 |
| Operating cash flow per share | −$0.23 | −$0.41 | $1.43 | $3.89 | −$0.24 | −$1.21 | $1.93 | −$1.46 | −$4.97 | $2.37 |
| Free cash flow per share | −$0.61 | −$0.92 | $1.05 | $3.11 | −$0.67 | −$1.63 | $1.46 | −$2.14 | −$5.89 | $1.28 |
| Cash per share | $0.76 | $1.36 | $2.51 | $1.40 | $1.65 | $4.55 | $5.43 | $3.33 | $1.36 | $7.48 |
| Book value per share | $2.78 | $2.97 | $2.72 | $2.54 | −$2.08 | −$6.71 | −$6.36 | −$1.51 | −$5.59 | $0.43 |
| Tangible book value per share | $2.69 | $2.86 | $2.07 | $1.74 | −$2.08 | −$6.71 | −$6.41 | −$1.51 | −$6.01 | −$5.72 |
| Dividends per share | — | — | — | — | — | — | $0.72 | $5.25 | $4.86 | $0.86 |
| Capex per share | $0.37 | $0.51 | $0.38 | $0.78 | $0.42 | $0.42 | $0.46 | $0.67 | $0.92 | $1.09 |
| Debt per share | $3.03 | $3.37 | $3.90 | $3.02 | $4.27 | $8.51 | $6.27 | $3.35 | $1.79 | $6.57 |
| Shares outstanding | 7.4M | 7.3M | 7.3M | 7.4M | 7.2M | 6.5M | 6.3M | 6.3M | 6.2M | 6.1M |
| Change in shares outstanding | +1.4% | −0.2% | −1.3% | +2.7% | +11.4% | +2.9% | +0.2% | +1.3% | +0.7% | −0.3% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −3.8% | −145.8% | −8.1% | — | — | — | — | — | — | −183.2% |
| Return on invested capital (ROIC) | 4.6% | 5.0% | 8.7% | 87.2% | — | — | — | — | — | — |
| Return on assets (ROA) | −0.8% | −26.0% | −1.3% | 32.3% | 13.2% | −1.4% | −21.8% | 13.7% | −24.3% | −41.7% |
| Return on tangible assets | −0.9% | −30.0% | −1.2% | 32.2% | 13.9% | −1.4% | −22.8% | 14.0% | −32.6% | −74.6% |
| Free cash flow margin | −2.8% | −3.6% | 4.0% | 11.1% | −2.5% | −6.0% | 4.2% | −4.7% | −9.5% | 2.0% |
| Income quality (OCF / net income) | — | — | — | 0.78 | −0.12 | — | — | −0.52 | — | — |
| Financial health | ||||||||||
| Total debt | $22.4M | $24.6M | $28.5M | $22.3M | $30.8M | $55.1M | $39.4M | $21.0M | $11.1M | $40.4M |
| Cash & short-term investments | $5.6M | $9.9M | $18.4M | $10.4M | $11.9M | $29.4M | $34.1M | $20.9M | $8.4M | $46.0M |
| Net debt | $16.8M | $14.7M | $10.1M | $12.0M | $18.9M | $25.6M | $5.3M | $101,000 | $2.7M | −$5.6M |
| Debt / equity | 1.09 | 1.13 | 1.44 | 1.19 | — | — | — | — | — | 15.22 |
| Debt / assets | 0.24 | 0.24 | 0.22 | 0.19 | 0.29 | 0.46 | 0.34 | 0.17 | 0.08 | 0.19 |
| Net debt / EBITDA | 4.85 | 1.22 | 0.76 | 0.53 | 0.96 | — | — | — | — | — |
| Current ratio | 1.54 | 1.53 | 1.36 | 1.52 | 1.78 | 1.83 | 1.74 | 1.94 | 1.53 | 1.43 |
| Quick ratio | 1.54 | 1.53 | 1.32 | 1.47 | 1.48 | 1.83 | 1.73 | 1.93 | 1.53 | 1.42 |
| Interest coverage | 8.7 | 11.2 | 24.9 | 34.5 | 8.5 | -9.1 | -17.1 | -16.8 | -8.5 | -16.1 |
| Working capital | $16.2M | $18.5M | $17.1M | $22.7M | $32.9M | $39.0M | $33.8M | $50.8M | $36.0M | $44.8M |
| Invested capital | $37.3M | $36.4M | $30.0M | $30.8M | $3.9M | −$17.8M | −$34.7M | −$9.4M | −$31.9M | −$2.9M |
| Tangible asset value | $19.9M | $20.8M | $15.1M | $12.9M | −$15.0M | −$43.4M | −$40.3M | −$9.5M | −$37.2M | −$35.2M |
| Net current asset value | −$25.0M | −$26.5M | −$46.0M | −$34.9M | −$47.5M | −$76.7M | −$76.1M | −$29.6M | −$62.2M | −$61.4M |
| Graham number | — | — | — | $16.85 | — | — | — | — | — | — |
| Graham net-net per share | −$5.20 | −$5.52 | −$8.24 | −$6.83 | −$8.56 | −$15.75 | −$14.53 | −$11.34 | −$15.46 | −$15.90 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | $4.5M | $32.9M | $30.1M | $5.3M |
| Share buybacks (net) | $65,000 | $295,000 | $3.0M | $469,000 | $291,000 | $22,000 | $6,000 | $115,000 | $111,000 | $233,000 |
| Dividend payout ratio | — | — | — | — | — | — | — | 187.6% | — | — |
| Dividends + buybacks / free cash flow | — | — | 39.3% | 2.0% | — | — | 49.0% | — | — | 69.9% |
| Capex / revenue | 1.7% | 2.0% | 1.5% | 2.8% | 1.6% | 1.5% | 1.3% | 1.5% | 1.5% | 1.7% |
| Capex / operating cash flow | — | — | 26.8% | 20.1% | — | — | 23.9% | — | — | 45.9% |
| Capex / depreciation | 0.62 | 0.85 | 0.66 | 2.13 | 1.19 | 0.75 | 0.54 | 0.56 | 0.54 | 0.54 |
| Stock-based compensation / revenue | 0.2% | 1.0% | 0.7% | 1.1% | 0.8% | 0.4% | 0.5% | −0.2% | 0.7% | 0.7% |
| SG&A / revenue | 64.6% | 62.9% | 62.0% | 59.5% | 65.7% | 70.8% | 67.2% | 69.6% | 70.5% | 72.2% |
| Efficiency | ||||||||||
| Days sales outstanding | 87.1 | 80.9 | 90.0 | 96.8 | 93.2 | 84.5 | 80.8 | 88.5 | 80.9 | 86.9 |
| Days of inventory on hand | — | — | 12.6 | 41.2 | 46.0 | 1.5 | 1.9 | 1.9 | 2.4 | 2.8 |
| Days payables outstanding | 127.7 | 145.0 | 139.8 | 107.2 | 117.7 | 123.0 | 115.3 | 122.3 | 136.7 | 128.0 |
| Cash conversion cycle (days) | -40.6 | -64.1 | -37.3 | 30.8 | 21.5 | -37.0 | -32.6 | -31.9 | -53.4 | -38.3 |
| Receivables turnover | 4.19 | 4.51 | 4.06 | 3.77 | 3.92 | 4.32 | 4.52 | 4.13 | 4.51 | 4.20 |
| Payables turnover | 2.86 | 2.52 | 2.61 | 3.40 | 3.10 | 2.97 | 3.16 | 2.98 | 2.67 | 2.85 |
| Inventory turnover | — | — | 29.02 | 8.87 | 7.93 | 246.45 | 189.28 | 193.73 | 153.11 | 130.07 |
| Asset turnover | 1.65 | 1.59 | 1.53 | 1.81 | 1.71 | 1.51 | 1.81 | 2.22 | 2.23 | 1.29 |
| Average receivables | $38.1M | $41.1M | $47.2M | $54.7M | $49.7M | $41.0M | $48.2M | $69.0M | $85.1M | $96.3M |
| Average payables | $17.5M | $22.5M | $22.8M | $19.3M | $16.2M | $16.6M | $24.0M | $33.6M | $40.8M | $41.1M |
| Average inventory | — | — | $2.1M | $7.4M | $6.3M | $200,000 | $401,000 | $517,500 | $712,500 | $900,500 |
| Intangibles / total assets | 0.7% | 0.8% | 3.6% | 4.9% | 0.0% | 0.0% | 0.3% | 0.0% | 2.0% | 17.7% |
Computed from HHS's annual financial statements (latest annual report filed March 17, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
HHS valuation and financial ratios
Harte Hanks earned a return on equity of −3.8% and a return on invested capital of 4.6% in fiscal 2025. It ended the year with $22.4 million of debt and $5.6 million in cash and short-term investments, net debt of $16.8 million. It returned $0.1 million to shareholders: $0 in dividends and $0.1 million in share buybacks. The share count rose 20.2% from 6.1M to 7.4M over 9 years.
See the HHS income statement, the HHS chart for price history, or the HHS stock overview for the latest quote and news.
HHS key metrics FAQ
What is Harte Hanks's EV/EBITDA?
Harte Hanks's enterprise value was 11.3 times EBITDA at the end of fiscal 2025 (enterprise value $39.1 million, EBITDA $3.5 million); the current EV/EBITDA is 4.5.
What is Harte Hanks's return on equity?
Harte Hanks's return on equity (ROE) was −3.8% in fiscal 2025: net income of -$0.8 million on average shareholders' equity of $21.1 million.
What is Harte Hanks's ROIC?
Harte Hanks's return on invested capital was 4.6% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Harte Hanks have?
Harte Hanks had total debt of $22.4 million at the end of fiscal 2025, a debt-to-equity ratio of 1.09 and $16.8 million of net debt (4.85 times EBITDA).
Does Harte Hanks buy back its shares?
Yes. Harte Hanks spent $0.1 million on net share repurchases in fiscal 2025 Shares outstanding changed +1.4% over the year, to 7.4M..
What is Harte Hanks's free cash flow yield?
Harte Hanks generated -$4.5 million of free cash flow in fiscal 2025, a free cash flow yield of −20.2% on its market value at year-end ($22.3 million).
What is Harte Hanks's current ratio?
Harte Hanks's current ratio was 1.54 at the end of fiscal 2025: current assets were 1.54 times current liabilities.